Racotumomab in Patients With High-risk Neuroblastoma

NCT02998983 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Racotumomab

Sponsor

Laboratorio Elea Phoenix S.A.